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Introduction
Catalysis is the most efficient strategy for the preparation of
enantiopure products.[1,2] Homogeneous and enzymatic cataly-
ses are in many respects complementary in terms of substrate
and reaction scope, operating conditions, enantioselection
mechanism, etc.[3] In terms of performance optimization, direct-
ed evolution methodologies outperform combinatorial ligand
libraries.[4–8]
With the aim of combining the best of both homogeneous
and enzymatic worlds (e.g. , reaction scope and performance
optimization), the field of artificial metalloenzymes has wit-
nessed a revival. The underlying principle of artificial metal-
loenzymes, relying on the “chemical mutation” of a protein to
incorporate a metal-containing fragment, was developed in
the late 1970s by Kaiser and Whitesides (Figure 1).[9–11]
Several recent reviews on artificial enzymes
exist ;[12–18] this minireview focuses on the latest devel-
opments in artificial metalloenzymes for enantioselec-
tive catalysis. The hybrid catalysts presented here are
classified according to the nature of the metal frag-
ment–host protein interaction: supramolecular,
dative, and covalent. For simplicity (and irrespective
of the nature of the metal fragment–host protein in-
teraction), the inclusion symbol “” will be used
throughout the review to describe artificial metal-
loenzymes: metal fragmenthost protein.[19]
Supramolecular Anchoring Strategies
The strongest noncovalent interaction (Ka1015m1)
between a protein and a small molecule is represent-
ed by the biotin–avidin couple.[20] This interaction is
thus strong enough to ensure quantitative localiza-
tion of a biotinylated metal fragment within a protein
environment without requiring a covalent modification step
that might not be quantitative. Functionalization of biotin with
a rhodium diphosphine moiety affords, upon mixing with
avidin, an artificial metalloenzyme for the reduction of func-
tionalized alkenes. Wilson and Whitesides demonstrated this
principle in 1978 in the reduction of N-acetamidoacrylate with
a 0.2 mol% catalyst loading (Scheme 1), obtaining N-acetami-
doalanine (N-AcAla) in 41% ee (S) and with quantitative con-
version.[11] In 1999, Chan and co-workers hydrogenated itaconic
acid in the presence of an enantiopure biotinylated pyrphos
ligand (Scheme 1B).[21] Depending on the operating conditions
(temperature, pressure, pH) and the absolute configuration of
the pyrphos ligand, the enantiopurity of the resulting methyl-
succinic acid varied between 48% (R) and 26% (S).
Inspired by these findings, we reported in 2003 a biotin–
streptavidin-based artificial metalloenzyme for the hydrogena-
tion of a-acetamidoacrylic acid and subsequently of a-acetami-
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Figure 1. Artificial metalloenzymes for enantioselective catalysis based on
the incorporation of a catalytically active metal fragment within a host pro-
tein. The interaction between the metal fragment and the host protein may
variously be supramolecular, dative, or covalent in nature.
Scheme 1. Artificial metalloenzymes based on biotin–avidin technology for the hydroge-
nation of alkenes; operating conditions used by Whitesides (A) and ligand used by Chan
for the reduction of itaconic acid (B).
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docinnamic acid.[22] Good levels
of enantioselection were ob-
tained upon substitution of
avidin by streptavidin (Sav here-
after), which is known to possess
a deeper binding pocket. Intro-
duction of a spacer between the
biotin anchor and the diphos-
phine moiety allows for chemical
optimization of the performance
of the artificial hydrogenas-
es.[23–25] Genetic optimization by
introduction of point mutations
on the host protein allows both
the activity and the selectivity of
the hybrid catalysts to be fine-
tuned. This chemo-genetic opti-
mization scheme (a term initially
coined by Distefano[13]) allows
the rapid generation of sub-
strate-specific and either (R)- or
(S)-selective artificial metalloen-
zymes (Table 1).[26]
These results highlight the
versatility of the chemogenetic
optimization scheme. The na-
tures of the spacer, the ligand,
and the aminoacid residue at
position 112, identified as a
close-lying residue (Table 1,
entry 2), all work in concert to
afford either (R)- or (S)-selective catalysts (up to 94% ee (R),
Table 1, entries 1, 3 and 9; up to 88% ee (S), Table 1, entries 4–
7). Other combinations yield substrate-specific hybrid catalysts
that convert the smaller substrate, leaving the larger substrate
nearly untouched (Table 1, entry 8).
Motivated by these findings, we next focused on enantiose-
lective transfer hydrogenation reactions catalyzed by d6-piano-
stool complexes. Using the same type of chemogenetic optimi-
zation procedure, we identified efficient artificial transfer hy-
drogenases for the enantioselective reduction of prochiral ke-
tones (Table 2).[27,28]
Several noteworthy conclusions can be drawn from these
data:
1) The initial pH plays a critical role.
2) The para-substituted biotinylated ligand Biot-p-L is most
effective with these substrates (Table 2).
3) The nature of the capping arene plays a critical role in
ACHTUNGTRENNUNGdetermining which enantiomer is produced: h6-benzene-
capped piano stools preferentially afford (S) products, while
h6-p-cymene affords (R) alcohols (Table 2, entries 2–4).
4) Cationic residues in position S112 favor (S)-reduction prod-
ucts (Table 2, entry 2).
In the context of supramolecular anchoring of metal cofac-
tors within a host protein, albumins play a key role. Serum al-
Table 1. Operating conditions and numerical summary of selected results of the chemogenetic optimization of
artificial hydrogenases in the reduction of a-acetamidoacrylic and a-acetamidocinnamic acid.
N-AcPhe N-AcAla
Ligand Sav mutant ee Conv. ee Conv.
1 Biot-1 WT Sav 93 (R) 84 94 (R) quant.
2 Biot-1 S112C 90 (R) 10 76 (R) 19
3 Biot-1 S112P 87 (R) 96 31 (R) quant.
4 Biot-4meta-1 S112H 81 (S) 88 58 (S) quant.
5 Biot-4meta-1 S112K 88 (S) 89 63 (S) quant.
6 Biot-4meta-1 S112P 78 (S) quant. 36 (S) quant.
7 Biot-4meta-1 S112R 86 (S) 71 63 (S) quant.
8 Biot-2 S112P 41 (S) 12 63 (S) quant.
9 Biot-34-2 S112Q 92 (R) 77 87 (R) quant.
N-AcPhe=a-acetamidophenylalanine. N-AcAla=a-acetamidoalanine. quant.=quantitative conversion.
Table 2. Operating conditions and numerical summary of selected results for
the chemogenetic optimization of enantioselective artificial transfer hydroge-
nases [h6-(arene)Ru ACHTUNGTRENNUNG(Biot-p-L)Cl]Sav.
h6-arene Sav mutant Substrate Conv. [%] ee [%]
1 p-cymene S112A 5 97 69 (R)
2 benzene S112R 6 95 70 (S)
3 p-cymene P64G 7 92 94 (R)
4 p-cymene S112Y 8 79 97 (R)
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bumins, which function as transport proteins in plasma, display
a remarkable ability to bind a variety of hydrophobic guests
tightly, including fatty acids, steroids, thyroxine, porphyrins,
etc.
These transport proteins have been shown to catalyze a
variety of enantioselective transformations, including oxi-
dation,[29–31] reduction,[32,33] and Diels–Alder cycloaddition[34]
reactions, with moderate to good enantioselectivities
(Scheme 2).[35]
The recent structural determination of a heminHSA 1:1
conjugate by Curry and co-workers[36] coincided with the de-
velopment of enantioselective artificial metalloenzymes based
on the noncovalent incorporation of corroles and phthalocya-
nines in serum albumins.[37,38]
Gross and co-workers have reported on the incorporation of
amphiphilic bis-sulfonated corrole metal complexes in various
serum albumins. In particular, [MnIIIACHTUNGTRENNUNG(corrole)]HSA displays a
1:1 conjugate with a Kd in the nanomolar range. The presence
of an induced circular dichroism signal suggests that the metal
is incorporated in a well-defined chiral environment,[37, 39] con-
sistently with the structurally characterized heminHSA conju-
gate.
The resulting artificial metalloenzyme catalyzes the enantio-
selective sulfoxidation of thioanisole derivatives (Table 3, up to
74% ee).[37] The Mn ACHTUNGTRENNUNG(corrole) derivatives are superior to Fe-
ACHTUNGTRENNUNG(corrole) in terms of activity, selectivity, and stability of the cat-
alyst. While PhIO affords higher yields of sulfoxide, its associat-
ed enantioselectivity is smaller than that obtained with H2O2.
Mechanistic investigations suggest the importance of a hydro-
gen peroxide coordinated to manganese ACHTUNGTRENNUNG(III) as the prime inter-
mediate in the enantioselective sulfoxidation.
Incorporation of Cu(phthalocyanine) in a variety of serum al-
bumins affords an efficient artificial metalloenzyme for Diels–
Alder cycloadditions. Excellent endo-selectivities and enantiose-
lectivities are reported for pyridine-bearing dienophiles with
both BSA and HSA as host protein (up to 98% ee with a
10 mol% catalyst loading; Table 4, entries 1–3). Although the
Cu(phthalocyanine) can formally accommodate two additional
donors, the geometry imposed by the aromatic phthalocya-
nine virtually excludes an NO chelation of the dienophile. As
the nonchelating dienophile, devoid of an N-donor, is a very
poor substrate (Table 4, entry 4), one can speculate that the
pyridine functionality interacts with the host protein rather
than the copper center, thus being reminiscent of enzymatic
catalysis, in which the protein steers the delivery of the sub-
strate to the coenzyme through noncovalent interactions.
Although serum albumins with no additional metal com-
plexes have been shown to catalyze both sulfoxidation and
Diels–Alder reactions (see Scheme 2), the reports by Gross and
Reetz unambiguously exclude catalytic activity of the protein
alone. As the heminHSA complex was shown to be anchored
through an interaction between a tyrosine Y161 and the iron
ion, one can speculate that both the Mn-corrole and the Cu-
phthalocyanine also enter into interaction with an amino acid
side chain within the albumin host protein.
In the context of hybrid catalysts for enantioselective Diels–
Alder cycloadditions, Roelfes and Feringa reported on a supra-
molecular catalyst relying on the intercalation of a copper-
based Lewis acid in salmon testes DNA (Table 5).[40,41]
Chemical optimization of the performance was achieved by
replacing the intercalator-spacer-donor 9a by a bipyridine
Scheme 2. Selected examples of : A) asymmetric sulfoxidation, B) epoxida-
tion, c) reduction, and d) Diels–Alder cycloaddition catalyzed by bovine
serum albumin.
Table 3. Albumin-conjugated corrole metal complexes as artificial metal-
loenzymes for the enantioselective sulfoxidation of thioanisole derivatives
(BSA, PSA=bovine and porcine serum albumin, respectively).
Host protein M X Conv. [%] ee [%]
1 BSA Mn F 76 68 (S)
2 PSA Mn F 98 65 (S)
3 BSA Mn Br 16 74 (S)
4 BSA Fe H 87 38 (S)
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ligand 9b, which acts both as intercalator and as bidentate
ligand. Excellent endo-selectivities and enantioselectivities are
reported for the Diels–Alder reactions between cyclopenta-
diene and bidentate dienophiles (Table 5).[40,41] Although the
catalyst loading remains very high at this stage, such hybrid
catalysts offer an attractive alternative to artificial metalloen-
zymes based on proteins as hosts.
Dative Anchoring Strategies
To the best of our knowledge, Kaiser and co-workers
were the first to modify the active site of an enzyme
by dative modification to afford an artificial metal-
loenzyme with novel catalytic properties. This ap-
proach was termed chemical mutation and the first
report detailed a study of the oxidase activity of a
copper(II) carboxypeptidase A (CPA).[9]
Substitution of zinc by copper in CPA affords a
CuIICPA conjugate that is inactive towards the hy-
drolysis of amides and esters. Spectroscopic studies
suggest that the copper adopts a distorted N2O2 tet-
rahedral geometry and is capable of binding to typi-
cal CPA inhibitors such as b-phenylpropionate as well
as to (rac)-a-benzylsuccinate.[9,42]
In the presence of oxygen, this artificial metalloen-
zyme CuIICPA was shown to be an effective catalyst
for the oxidation of ascorbic acid to dehydroascorbic
acid. In contrast to the solvated copper(II) ion,
CuIICPA follows Michaelis–Menten kinetics
(Scheme 3).
The first enantioselective artificial metalloenzyme
based on the dative anchoring of a metal moiety was
reported by Kokubo in 1983.[43] Introduction of
osmium tetroxide into BSA yields a 1:1 complex that
displays remarkable catalytic dihydroxylation proper-
ties in the presence of tert-butylhydroperoxide as oxi-
dant (Scheme 4). The authors speculate that the OsO4
moiety is anchored through two dative bonds to
lysine residues within BSA’s hydrophobic pocket. For
the dihydroxylation of a-methylstyrene, enantioselec-
tivities of up to 68% (S) have been reported. This
early study once again highlights the potential of al-
bumins as host proteins for enantioselective catalysis.
A pentacoordinate vanadate ion can be regarded
as a transition state analogue for phosphate hydroly-
sis,[44] and this property can be exploited for efficient
inhibition of the hydrolytic activity of acid phospha-
tases[45] and phytases.[46]
Close inspection of the active site of vanadium
chloroperoxidase from C. inaequalis[47] reveals a strik-
ing similarity to the active site of phytase from
A. ficuum (Scheme 5),[47,48] and as a result of this ob-
servation Sheldon and co-workers investigated the
sulfoxidation properties of a vanadium-incorporated
phytase.[49–52] After incorporation of vanadate into
Table 4. Selected results for Diels–Alder reactions catalyzed by Cu(phthalocya-
nine)serum albumin (BSA, HSA=bovine and human serum albumin).
Host protein R X Conv. [%] endo :exo ee endo [%]
1 BSA H N 80 96:4 93
2 HSA H N 89 91:9 85
3[a] BSA NO2 N 91 91:9 98
4 BSA H CH 5 – 56
[a] 10 mol% catalyst loading
Table 5. Asymmetric Diels–Alder reactions catalyzed by DNA-based catalysts in the
presence of aromatic bidentate ligands as DNA intercalators.
Ligand R endo:exo ee endo [%] ee exo [%]
1[a] 9a 4-methoxyphenyl 91:9 53[b] 90[b]
2 9b 4-methoxyphenyl >99:1 >99 –
3 9b Ph >99:1 99 –
4 9b tBu >99:1 97 –
Conversion>80% for all reactions. [a] 5 equivalents of cyclopentadiene. [b] The nega-
tive sign refers to the opposite enantiomer, absolute configuration not determined.
Scheme 3. Oxidase activity of copper(II) carboxypeptidase A (CuIICPA), the
first artificial metalloenzyme.
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phytase from A. ficuum, the resulting semisynthetic peroxidase
displayed moderate enantioselectivity (up to 66% ee (S) at
4 8C, TOF=11 min1) for the sulfoxidation of thioanisole deriva-
tives in the presence of hydrogen peroxide, with very little de-
tectable overoxidation (Scheme 5).
Various other vanadium-loaded enzymes (including BSA,
apo-ferritin, sulfatase, phospholipase, acid phosphatase, etc)
were tested in the sulfoxidation of thioanisole: phytase from
A. ficuum gave the highest rate and the highest enantioselec-
tivity. The vanadate performs best of a range of oxoanions
combined with phytase, in terms of both activity and selectivi-






3.[51] Similarly, substitution of
Zn2+ from thermolysin by a tungstate yields a moderately
active—but nonenantioselective—sulfoxidation artificial metal-
loenzyme.[53] From the restored proteolytic activity of tung-
statethermolysin, as well as its sulfoxidation activity towards
phenylmercaptoacetophenone, the authors tentatively con-
clude that the anion is “correctly bound in the active site”, de-
spite its size and charge.[53]
Surprisingly, the phytase with no vanadium also catalyzes
the enantioselective sulfoxidation of thioanisole (up to 66% ee
(S) at 4 8C), although the sulfoxidation rate for the vanadium-
free phytase-catalyzed reaction is significantly lower than that
for the semisynthetic enzyme incorporating vanadium:
3.2 mmolh1 vs. 124 mmolh1.[50]
Phytase, a hydrolytic enzyme, can thus be converted into a
peroxidase, with no modification of the active site. Such pro-
pensity of enzymes to catalyze more than one distinct chemi-
cal transformation, known as catalytic promiscuity, has recently
been reviewed by Bornscheuer and Kazlauskas.[18]
The zinc in carbonic anhydrase (CA) can be substituted by
various transition metals, including manganese. Incorporation
of catalytically non-innocent manganese in apo-carbonic anhy-
drase affords an artificial metalloenzyme MnCA for the enan-
tioselective epoxidation of aromatic olefins: up to 67% ee (R)
for p-chlorostyrene (Scheme 6).[54] Interestingly, percarbonate
(HCO4
 prepared from HCO3
 and H2O2)
[55] proved to be the
best oxidizing agent: upon oxidation of the olefin, carbon-
ate—which is the natural substrate of CA—is formed. Mass
spectroscopic analysis during catalysis suggests that oxidative
degradation of MnCA limits the turnover number.
Very similar results were reported nearly simultaneously by
Soumillon and co-workers for the epoxidation of styrene in the
presence of MnCA (up to 52% ee (R) and 9% yield with
bovine carbonic anhydrase). Interestingly, they reported that a
phosphate buffer affords the best selectivities as it shuts off
the background epoxidation reaction of the non-protein-incor-
porated manganese ions.[56]
Substitution of the heme cofactor by [M(Schiff base)] moiet-
ies in myoglobin (Mb) to yield artificial metalloenzymes for
enantioselective sulfoxidation was first reported by Watanabe
and co-workers.[57–58] In addition to van der Waals interactions
between the coordination compound and Mb, a dative bond
between Histidine H93 and the metal center ensures localiza-
tion of the catalyst. Selected results for the sulfoxidation of thi-
oanisole are collected in Table 6, entries 1–4. Initial results
(Table 6, entry 1)[57] could subsequently be improved by analy-
sis of an X-ray crystal structure, which led to the rational
design of site-directed Mb mutants.[58] Chemo-genetic optimi-
zation affords more active—and both (S)- and (R)-selective—
hybrid catalysts (up to 33% (S) and 27% (R), entries 2–4; for
entries 5 and 6, vide infra).
Scheme 4. Artificial enantioselective dihydroxylase based on the dative
ACHTUNGTRENNUNGanchoring of OsO4 in BSA.
Scheme 5. Design of a semisynthetic peroxidase based on the incorporation
of vanadate in phytase (A), yielding a vanadium chloroperoxidase-like active
site (B). In the presence of hydrogen peroxide, the vanadium-incorporated
phytase catalyzes the enantioselective oxidation of thioanisole derivatives
(C).




In the context of covalent modification of proteins to afford ar-
tificial enzymes, two papers come to mind.[10,59]
Once again, Kaiser was the first to demonstrate that novel
catalytic functions can be created by covalent modification of
an amino acid residue with appropriately modified coenzyme
analogues. His group reported in 1977 that flavopapain can be
converted into a highly effective oxidoreductase by covalent
modification of the thiol group of cysteine C25 with flavins.
The resulting flavopapains exhibit significant rate enhance-
ments (up to 670-fold) over native enzymes for the oxidation
of dihydronicotinamides.[60]
Hilvert developed a chemical methodology for the conver-
sion of the serine S221, buried within subtilisin’s active site,
into selenocysteine.[59,61] This semisynthetic enzyme was shown
to:
1) function both as an acyl transferase, and
2) mimic glutathione peroxidase.
The first report on artificial metalloenzymes for enantioselec-
tive catalysis based on covalent anchoring was published by
Distefano and co-workers,[13,62] who reported on the
preparation of a 1,10-phenanthroline covalently
linked to the adipocyte lipid-binding protein (Phen
ALBP). The unique cysteine residue cysteine C117, lo-
cated in the interior of ALBP, reacts with iodoacetami-
do-1,10-phenanthroline to afford a thioether-linked
artificial apo-metalloenzyme. After loading with CuII,
the resulting hybrid catalyst CuIIPhenALBP catalyzes
the enantioselective hydrolysis of several unactivated
amino acid ester substrates (Table 7).
This fascinating study reveals good kinetic resolu-
tion properties, but the turnover numbers leave
room for improvement (Table 7, entries 3 and 5).
Lu and co-workers recently reported an enantiose-
lective artificial sulfoxidation metalloenzyme based
on a dual covalent anchoring strategy of a Mn(Schiff
base) within Mb (Table 6).[63] The study suggests that
dual anchoring to the L72C/Y103C Mb double
mutant through two disulfide bridges, combined
with the histidine H93 dative anchoring, affords
higher selectivities than the related dative anchoring
strategy pursued by Watanabe and co-workers for
the sulfoxidation of thioanisole[57,58] (up to 51% ee
(R), Table 6, compare entries 1–4 with entries 5 and
6).
Since 2002, several groups have reported on their
progress toward the covalent anchoring of achiral
metal-containing catalyst precursors within host pro-
teins to afford artificial metalloenzymes for enantiose-
lective catalysis (Scheme 7). Reetz was the first to
report covalent anchoring to papain, through Mi-
chael additions of the cysteine C25 to the maleini-
mide-derivatized Schiff base 10 or the bis-pyridine 11
(Scheme 7A and B). Alternatively, a diphosphine 12
Table 6. Operating conditions and selected results for the sulfoxidation of thioanisole
catalyzed by [M-(Schiff base)]Mb mutants.
M(R2-Schiff base) Mb mutant Rate
[a] ee [%]
1 Cr 5,5’-tBu2 ACHTUNGTRENNUNG(salophen) H64D/A71G 78 13 (S)
2 Cr 3,3’-Me2ACHTUNGTRENNUNG(salen) H64D/A71G 210 33 (S)
3 Mn 3,3’-Pr2ACHTUNGTRENNUNG(salen) A71G 2724 27 (R)
4 Mn 3,3’-Me2ACHTUNGTRENNUNG(salen) H64D/A71G 464 32 (S)
5[b] Mn 4,4’-thio2ACHTUNGTRENNUNG(salen)
[c] Y103C 51 12 (S)
6[b] Mn 4,4’-thio2ACHTUNGTRENNUNG(salen)
[d] L72C/Y103C 390 51 (S)
[a] Rate unit : 103 turnover min1. [b] Reaction conditions: NH4OAc (50 mm), pH 5.1 at
4 8C, catalyst (130 mm), thioanisole (5 mm), H2O2 (6.5 mm). [c] Single anchoring through
a disulfide bridge. [d] Double anchoring through two disulfide bridges.
Table 7. Preparation of CuIIPhenALBP, operating conditions, and select-
ed results for the enantioselective hydrolysis of amino acid ester deriva-
tives.
R R’ TON ee [%] kcat(D) [m
1 s1] kcat(L) [m
1 s1]
1 Me Me 5.5 67 850 4200
2 Me Et 3.0 40 830 1900
3 Me iPr 1.3 86 88 1200
4 HOC6H4CH2 Me 7.6 39 2100 4900
5[a] HOC6H4CH2 Me 0.7 86 44 600
[a] T=4 8C. TON: turnover number.
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was covalently anchored to a serine within a lipase through a
phosphonate (Scheme 7D).[64] Catalyst localization was unam-
biguously established by enzyme inhibition experiments. In
the case of the diphosphine 12lipase, however, esterase ac-
tivity was largely restored within a day, suggesting release of
the phosphonate ligand 12.
Catalytic epoxidation and hydrogenation activity were de-
tected for [MnCl(Schiff base 10)]papain and for [RhCl3 (bis-
pyridine 11)]papain. Unfortunately, the enantioselectivity
turned out to be less than 10%.[64]
In a related study, de Vries and Feringa reported on the co-
valent anchoring of the monophosphite 12 to cysteine C25 in
papain. In the presence of RhI, the [RhOH(phosphite 12)]
papain catalyzes the reduction of methyl acetamidoacrylate.
Although the artificial metalloenzyme displays good activities
(quantitative conversion in the presence of 0.25 mol% within
15 h at room temperature), no enantioselectivity was detect-
ed.[65]
The reversible binding problem encountered with diphos-
phine 12lipase could be circumvented by using a pincer-type
ligand bearing a phosphonate ester with a single nitrophenol
leaving group.[66] Upon reaction
with cutinase, irreversible cova-
lent anchoring to serine S120
occurs enantioselectively
(Scheme 7E). No report on the
catalytic properties has thus far
been reported.
Outlook
The purpose of this minireview
is to present the state of the art
in the area of artificial metalloen-
zymes for enantioselective catal-
ysis from an historical perspec-
tive. All three anchoring strat-
egies (i.e. , supramolecular,
dative, and covalent) have been
exploited and, thus far, only the
supramolecular approach has
yielded good levels of enantiose-
lection: >90% for hydrogena-
tion, transfer hydrogenation, and
Diels–Alder cycloadditions.
As mentioned in the Introduc-
tion, the power of directed evo-
lution in optimizing enzymes is
unrivalled. The prospects for
combining both directed evolu-
tion protocols and chemical op-
timization are perhaps the most
attractive feature of such artifi-
cial metalloenzymes. The pres-
ence of a well-defined second
coordination sphere around an active catalyst might allow
regio- and enantioselective derivatization of unprotected sub-
strates containing several equally reactive functionalities. How-
ever, several technical hurdles must still be overcome:
1) Many metal-containing catalysts are incompatible with cel-
lular extracts. This drawback requires purification of the
host protein before anchoring of the metal moiety and per-
forming of catalysis.
2) In contrast with small-molecule catalysts (e.g. , organocata-
lysts), the molecular weights of the hybrid catalysts require
very high TONs for the systems to be economically viable.
Unfortunately, few water-compatible enantioselective cata-
lytic systems to date display TONs>1000. For illustration,
in the case of an artificial metalloenzyme (Mw=15 kDa)
with TON=1000 for a substrate (Mw=0.15 kDa), the total
mass of the catalyst would represent 10% of the mass of
the substrate.
3) While efficient screening or selection protocols exist for ki-
netic resolutions, the number of reliable, easy to imple-
ment, and cheap assays for the enantioselectivity are un-
fortunately rather limited.[5,67–71]
Scheme 7. Covalent anchoring of ligands and complexes to papain (A–C) and to lipases (D–E), and typical hydro-
genation conditions used with [RhOH(phosphite 12)]papain (F).
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